![]() |
Volumn 28, Issue 1, 2009, Pages 93-94
|
Miller - Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab
|
Author keywords
Adalimumab; Miller Fisher; Rheumatoid arthritis
|
Indexed keywords
ADALIMUMAB;
AZATHIOPRINE;
C REACTIVE PROTEIN;
GABAPENTIN;
METHOTREXATE;
PREDNISONE;
STEROID;
AGED;
ANESTHESIA (SENSORY DYSFUNCTION);
ARTICLE;
ATAXIA;
CASE REPORT;
CLINICAL FEATURE;
DIZZINESS;
DRUG DOSE INCREASE;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
ELECTROMYOGRAM;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
FEVER;
GUILLAIN BARRE SYNDROME;
HUMAN;
LABORATORY TEST;
NERVE STIMULATION;
NEUROLOGIC EXAMINATION;
NYSTAGMUS;
PHYSIOTHERAPY;
PNEUMONIA;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SENSORY DYSFUNCTION;
TENDON REFLEX;
TREATMENT RESPONSE;
AGED;
AMINES;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
AZATHIOPRINE;
CYCLOHEXANECARBOXYLIC ACIDS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GAMMA-AMINOBUTYRIC ACID;
GLUCOCORTICOIDS;
HUMANS;
MILLER FISHER SYNDROME;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 57049147427
PISSN: 07703198
EISSN: None
Source Type: Journal
DOI: 10.1007/s10067-008-1017-7 Document Type: Article |
Times cited : (18)
|
References (4)
|